Bringing a Biologic from the Bench to the Marketplace

Published on: June 3, 2015

Michiel E. Ultee of Ulteemit BioConsulting discusses converting an early drug discovery into a product that is ready for clinical testing.

In this video, Michiel E. Ultee, PhD, principal of Ulteemit BioConsulting, discusses converting an early drug discovery into a product that is ready for clinical testing, biologics license applications, and FDA guidance documents.

The video was shot at INTERPHEX 2015 in New York, NY.